Successful Treatment of Binge Eating Disorder With Combination Phentermine/Topiramate Extended Release.
作者信息
Guerdjikova Anna I, Fitch Angela, McElroy Susan L
机构信息
Lindner Center of HOPE, Mason, Ohio, and Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, Ohio (Drs Guerdjikova and McElroy); and Department of Internal Medicine, Department of Surgery, University of Cincinnati College of Medicine, Cincinnati, Ohio (Dr Fitch).
出版信息
Prim Care Companion CNS Disord. 2015 Apr 2;17(2). doi: 10.4088/PCC.14l01708. eCollection 2015.
Abstract
摘要
相似文献
1
Successful Treatment of Binge Eating Disorder With Combination Phentermine/Topiramate Extended Release.联合使用缓释苯丁胺/托吡酯成功治疗暴饮暴食症。
Prim Care Companion CNS Disord. 2015 Apr 2;17(2). doi: 10.4088/PCC.14l01708. eCollection 2015.
2
Combination Phentermine-Topiramate Extended Release for the Treatment of Binge Eating Disorder: An Open-Label, Prospective Study.复方缓释苯丁胺-托吡酯治疗暴饮暴食症：一项开放标签的前瞻性研究。
Innov Clin Neurosci. 2018 Jun 1;15(5-6):17-21.
3
Evaluation of phentermine and topiramate versus phentermine/topiramate extended-release in obese adults.在肥胖成年人中对比苯丁胺和托吡酯与缓释型苯丁胺/托吡酯的疗效评估。
Obesity (Silver Spring). 2013 Nov;21(11):2163-71. doi: 10.1002/oby.20584. Epub 2013 Oct 17.
4
Response of recurrent binge eating and weight gain to topiramate in patients with binge eating disorder after bariatric surgery.减肥手术后患有暴饮暴食症的患者复发性暴饮暴食和体重增加对托吡酯的反应。
Obes Surg. 2005 Feb;15(2):273-7. doi: 10.1381/0960892053268354.
5
Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial.托吡酯治疗与肥胖相关的暴饮暴食症：一项随机、安慰剂对照试验。
Am J Psychiatry. 2003 Feb;160(2):255-61. doi: 10.1176/appi.ajp.160.2.255.
6
Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial.低剂量、控释型、苯丁胺与托吡酯复方制剂对超重和肥胖成年人体重及相关合并症的影响（CONQUER）：一项随机、安慰剂对照、3 期临床试验。
Lancet. 2011 Apr 16;377(9774):1341-52. doi: 10.1016/S0140-6736(11)60205-5. Epub 2011 Apr 8.
7
Phentermine, topiramate and their combination for the treatment of adiposopathy ('sick fat') and metabolic disease.苯丁胺、托吡酯及其联合用药治疗脂肪代谢障碍（“病态肥胖”）和代谢性疾病。
Expert Rev Cardiovasc Ther. 2010 Dec;8(12):1777-801. doi: 10.1586/erc.10.125. Epub 2010 Aug 16.
8
Topiramate for the treatment of binge eating disorder associated with obesity: a placebo-controlled study.托吡酯治疗与肥胖相关的暴饮暴食症：一项安慰剂对照研究。
Biol Psychiatry. 2007 May 1;61(9):1039-48. doi: 10.1016/j.biopsych.2006.08.008. Epub 2007 Jan 29.
9
Lithium augmentation of topiramate for bipolar disorder with comorbid binge eating disorder and obesity.锂盐增强托吡酯治疗合并暴饮暴食症和肥胖症的双相情感障碍
Hum Psychopharmacol. 2006 Oct;21(7):425-31. doi: 10.1002/hup.783.
10
New obesity agents: lorcaserin and phentermine/topiramate.新型肥胖症治疗药物：lorcaserin 和 phentermine/topiramate。
Ann Pharmacother. 2013 Jul-Aug;47(7-8):1007-16. doi: 10.1345/aph.1R779. Epub 2013 Jun 25.
引用本文的文献
1
Novel potential pharmacological approaches in treating eating disorders comorbid with substance use disorders.治疗与物质使用障碍共病的饮食失调的新型潜在药理学方法。
Biomed Pharmacother. 2025 Aug;189:118327. doi: 10.1016/j.biopha.2025.118327. Epub 2025 Jul 4.
2
Medications for the treatment of obesity in adolescents.用于治疗青少年肥胖症的药物。
Ther Adv Endocrinol Metab. 2020 May 27;11:2042018820918789. doi: 10.1177/2042018820918789. eCollection 2020.
3
Combining cognitive bias modification training (CBM) and transcranial direct current stimulation (tDCS) to treat binge eating disorder: study protocol of a randomised controlled feasibility trial.将认知偏差修正训练（CBM）与经颅直流电刺激（tDCS）相结合治疗暴食症：一项随机对照可行性试验的研究方案。
BMJ Open. 2019 Oct 22;9(10):e030023. doi: 10.1136/bmjopen-2019-030023.
4
Clinical Considerations Regarding the Use of Obesity Pharmacotherapy in Adolescents with Obesity.临床考虑因素关于肥胖症药物治疗在肥胖青少年中的应用。
Obesity (Silver Spring). 2019 Feb;27(2):190-204. doi: 10.1002/oby.22385.
5
Progress in Developing Pharmacologic Agents to Treat Bulimia Nervosa.开发治疗神经性贪食症的药物制剂的进展。
CNS Drugs. 2019 Jan;33(1):31-46. doi: 10.1007/s40263-018-0594-5.
6
Combination Phentermine-Topiramate Extended Release for the Treatment of Binge Eating Disorder: An Open-Label, Prospective Study.复方缓释苯丁胺-托吡酯治疗暴饮暴食症：一项开放标签的前瞻性研究。
Innov Clin Neurosci. 2018 Jun 1;15(5-6):17-21.
7
Pharmacotherapy of eating disorders.饮食失调的药物治疗。
Curr Opin Psychiatry. 2017 Nov;30(6):452-457. doi: 10.1097/YCO.0000000000000358.
8
Emerging Treatments in Eating Disorders.饮食失调的新兴治疗方法。
Neurotherapeutics. 2017 Jul;14(3):614-622. doi: 10.1007/s13311-017-0535-x.
本文引用的文献
1
Current and emerging drug treatments for binge eating disorder.目前和新兴的暴食症药物治疗方法。
Expert Opin Emerg Drugs. 2014 Mar;19(1):99-142. doi: 10.1517/14728214.2014.879291. Epub 2014 Jan 25.
2
Phentermine and topiramate extended release (Qsymia™): first global approval.盐酸苯丁胺和托吡酯缓释片（Qsymia™）：全球首次批准。
Drugs. 2012 Oct 22;72(15):2033-42. doi: 10.2165/11640860-000000000-00000.
3
Topiramate for the treatment of binge eating disorder associated with obesity: a placebo-controlled study.托吡酯治疗与肥胖相关的暴饮暴食症：一项安慰剂对照研究。
Biol Psychiatry. 2007 May 1;61(9):1039-48. doi: 10.1016/j.biopsych.2006.08.008. Epub 2007 Jan 29.
4
The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication.《全国共病调查复制版中的饮食失调患病率及其相关因素》
Biol Psychiatry. 2007 Feb 1;61(3):348-58. doi: 10.1016/j.biopsych.2006.03.040. Epub 2006 Jul 3.
5
Lateral hypothalamic injections of glutamate, kainic acid, D,L-alpha-amino-3-hydroxy-5-methyl-isoxazole propionic acid or N-methyl-D-aspartic acid rapidly elicit intense transient eating in rats.
Brain Res. 1993 Jun 4;613(1):88-95. doi: 10.1016/0006-8993(93)90458-y.
6
Anorectic drugs: use in general practice.厌食药：在全科医疗中的应用。
Drugs. 1976;11(5):378-93. doi: 10.2165/00003495-197611050-00002.
Zotero 插件